Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)

NCT04070352 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT04070352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04070352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Withdrawn
Start date
August 1, 2019
Completion date
May 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection (cdi)